Literature DB >> 3031175

Aseptic meningitis due to varicella-zoster virus: serum antibody levels and local synthesis of specific IgG, IgM, and IgA.

J M Echevarría, P Martínez-Martín, A Téllez, F de Ory, J L Rapún, A Bernal, E Estévez, R Nájera.   

Abstract

We used an indirect enzyme immunoassay to describe the evolution of serum levels and the intrathecal production of IgG, IgA, and IgM antibodies to varicella-zoster virus (VZV) in eight patients with a syndrome of acute aseptic meningitis (AAM) and evidence of intrathecal production of VZV-specific IgG antibodies. Four of the eight patients showed no cutaneous zoster while hospitalized. Our results suggested an etiologic relation between VZV and AAM in all cases. Furthermore, we observed some differences in the pattern of evolution of antibodies in serum and cerebrospinal fluid in relation to the presence or absence of cutaneous lesions in our patients. These differences could reflect different pathogenic mechanisms in the spread of VZV to the central nervous system and in the production of the AAM syndrome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031175     DOI: 10.1093/infdis/155.5.959

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  Neurological disease produced by varicella zoster virus reactivation without rash.

Authors:  Don Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

2.  Dual detection of antibody to both herpes simplex and varicella-zoster viruses in cerebrospinal fluid: cross reactivity or dual infection?

Authors:  J M Echevarría; I Casas; A Tenorio; P Martínez-Martín
Journal:  J Neurol       Date:  1996-08       Impact factor: 4.849

3.  A woman with acute headache and sacral dermatomal numbness.

Authors:  R N Gunson; C Aitken; Don Gilden
Journal:  J Clin Virol       Date:  2010-12-03       Impact factor: 3.168

4.  Herpes simplex virus type 2 meningitis without genital lesions: an immunoblot study.

Authors:  D Boucquey; M P Chalon; C J Sindic; M E Lamy; C Laterre
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

5.  Varicella-zoster meningitis with a late-onset of skin eruption.

Authors:  Anawin Sanguankeo; Sikarin Upala; Suthanya Sornprom; Natanong Thamcharoen
Journal:  BMJ Case Rep       Date:  2015-02-17

6.  Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system.

Authors:  S M Gregoire; V van Pesch; S Goffette; A Peeters; C J M Sindic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-25       Impact factor: 10.154

7.  Soluble class I antigens in serum and CSF of patients with varicella-zoster virus meningitis.

Authors:  J Alvarez-Cermeño; J M Echevarría; L M Villar; I Lázaro; A Bootello; P González-Porque
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-10       Impact factor: 10.154

8.  The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system.

Authors:  K Felgenhauer; H Reiber
Journal:  Clin Investig       Date:  1992-01

9.  Detection of varicella-zoster virus DNA by polymerase chain reaction in cerebrospinal fluid of patients with herpes zoster meningitis.

Authors:  H Shoji; Y Honda; I Murai; Y Sato; K Oizumi; R Hondo
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

10.  Varicella zoster virus meningitis with hypoglycorrhachia in the absence of rash in an immunocompetent woman.

Authors:  Ali A Habib; Don Gilden; D Scott Schmid; Joseph E Safdieh
Journal:  J Neurovirol       Date:  2009-04       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.